Role of Uterine Artery Embolization in Management of Uterine Lesions with Abnormal Uterine Bleeding

M. Hammad, MS Alwaraky, MA Maaly, Mary A. Kamel, H. Hamza
{"title":"Role of Uterine Artery Embolization in Management of Uterine Lesions with Abnormal Uterine Bleeding","authors":"M. Hammad, MS Alwaraky, MA Maaly, Mary A. Kamel, H. Hamza","doi":"10.1177/0300891620914158","DOIUrl":null,"url":null,"abstract":"Introduction: Abnormal uterine bleeding is one of the most frequent gynecological and obstetrics problems. Till the recent decades, myomectomy and hysterectomy were the only treatment options available to control uterine bleeding regardless the morbidity and mortality. Over the past decade, uterine artery embolization (UAE) has become a popular alternative treatment. Our study aim is to evaluate the efficacy of UAE for the treatment of uterine bleeding of different etiologies as Fibroids & uterine arterio-venous malformation (AVM). Material & Methods: Thirty patients were enrolled in the study: 28 patients with fibroids & 2 patients with AVM, all underwent UAE by PVA for fibroid & Hystroacryl with lipidol & coils for AVM. Bleeding as an end point was Followed up for 6 months. Results: Cessation of bleeding with no recurrence through the 6 months of follow up. UAE significantly decreased the bleeding towels from 4.4 to 2 towels after 6 months. As well, the menstrual duration was reduced from 7.6 to 4.4 days (p < 0.05*). Hemoglobin level was boosted from 10.7 to 11.4 gm/dl after 6 months (p=0.001*). As well, the fibroid size was significantly reduced from 314.7 to 70.4 cm3 after 6 months (p < 0.05*). The AVM cases have completely recovered & one of them got pregnant with delivery of normal fetus with no reported complication. The majority of our patients showed high level of satisfaction with the obtained outcomes. Conclusion: UAE, either unilateral or bilateral, is a safe and effective technique for management of abnormal uterine bleeding of fibroids & AVM origin. A high clinical success rate and fibroid volume with the mean menstrual duration& amount reduction can be achieved.","PeriodicalId":23450,"journal":{"name":"Tumori Journal","volume":"46 1","pages":"27 - 27"},"PeriodicalIF":0.0000,"publicationDate":"2020-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tumori Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/0300891620914158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Abnormal uterine bleeding is one of the most frequent gynecological and obstetrics problems. Till the recent decades, myomectomy and hysterectomy were the only treatment options available to control uterine bleeding regardless the morbidity and mortality. Over the past decade, uterine artery embolization (UAE) has become a popular alternative treatment. Our study aim is to evaluate the efficacy of UAE for the treatment of uterine bleeding of different etiologies as Fibroids & uterine arterio-venous malformation (AVM). Material & Methods: Thirty patients were enrolled in the study: 28 patients with fibroids & 2 patients with AVM, all underwent UAE by PVA for fibroid & Hystroacryl with lipidol & coils for AVM. Bleeding as an end point was Followed up for 6 months. Results: Cessation of bleeding with no recurrence through the 6 months of follow up. UAE significantly decreased the bleeding towels from 4.4 to 2 towels after 6 months. As well, the menstrual duration was reduced from 7.6 to 4.4 days (p < 0.05*). Hemoglobin level was boosted from 10.7 to 11.4 gm/dl after 6 months (p=0.001*). As well, the fibroid size was significantly reduced from 314.7 to 70.4 cm3 after 6 months (p < 0.05*). The AVM cases have completely recovered & one of them got pregnant with delivery of normal fetus with no reported complication. The majority of our patients showed high level of satisfaction with the obtained outcomes. Conclusion: UAE, either unilateral or bilateral, is a safe and effective technique for management of abnormal uterine bleeding of fibroids & AVM origin. A high clinical success rate and fibroid volume with the mean menstrual duration& amount reduction can be achieved.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
子宫动脉栓塞在子宫病变合并子宫异常出血治疗中的作用
子宫异常出血是妇产科最常见的问题之一。直到最近几十年,子宫肌瘤切除术和子宫切除术是唯一可用于控制子宫出血的治疗选择,无论发病率和死亡率如何。在过去的十年中,子宫动脉栓塞术(UAE)已成为一种流行的替代治疗方法。我们的研究目的是评估阿联治疗子宫出血的不同病因,如肌瘤和子宫动静脉畸形(AVM)的疗效。材料与方法:本研究共纳入30例患者,其中肌瘤患者28例,AVM患者2例,肌瘤患者均行PVA联合UAE治疗,AVM患者均行盐酸丙烯酯联合脂醇联合线圈治疗。以出血为终点,随访6个月。结果:随访6个月,止血停止,无复发。6个月后,UAE将出血毛巾从4.4条减少到2条。月经持续时间由7.6 d缩短至4.4 d (p < 0.05*)。6个月后,血红蛋白水平从10.7提高到11.4 gm/dl (p=0.001*)。6个月后肌瘤大小由314.7 cm3减少至70.4 cm3 (p < 0.05*)。AVM病例均已完全康复,其中1例成功怀孕,分娩胎儿正常,无并发症报道。我们的大多数患者对获得的结果表示高度满意。结论:单侧或双侧子宫联合栓塞术是治疗子宫肌瘤及AVM源性子宫异常出血安全有效的方法。临床成功率高,肌瘤体积大,平均月经时间和数量减少。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
PROACT 2.0: A new open-source tool to improve patient-doctor communication in clinical trials Response to lorlatinib rechallenge in a case of ALK-rearranged metastatic NSCLC with a resistance mutation to second generation TKIs The digital revolution in pathology: Towards a smarter approach to research and treatment The power of art and the powers of adolescents with cancer: Age-specific projects at Italian pediatric oncology centers bgicc 2024 abstracts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1